Literature DB >> 16170660

Sick leave due to depressive disease: not a risk factor for the development of malignant lymphoma.

Marie Nordström1, Fredrik Granath, Magnus Björkholm, Anders Ekbom.   

Abstract

For unknown reasons the incidence of non-Hodgkin's Lymphomas (NHL) has increased during the last decades. Conditions with impaired immune functions have been associated with an increased risk of malignant lymphomas. Interactions between the central nervous, immune, and endocrine systems have been recently identified, and the potential physiological importance of these interactions is being explored. In this prospective cohort study the potential association between an increasing incidence of depressive disorders and the development of malignant lymphoma is being explored. The participants were part of the Swedish manpower on sick leave between 1988 and 2000 with depressive disease for more than two weeks were followed until a diagnosis of lymphoid malignancy, death, emigration, or end of follow-up period. The final cohort included 87,677 individuals with 373,135 years of follow-up. There were 80 cases of NHL, chronic lymphocytic leukemia (CLL), and Hodgkin lymphoma (HL) with 70 cases expected. The first year of follow-up showed a slightly increased risk of NHL, which most probably can be interpreted as initial symptoms of lymphoma. We conclude that the increase in the incidence of malignant lymphomas observed during the last decades seems not to be associated with a concurrent increase of depressive disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170660     DOI: 10.1007/s10654-005-1050-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  28 in total

1.  Antidepressant medications and risk for cancer.

Authors:  S O Dalton; C Johansen; L Mellemkjaer; H T Sørensen; J K McLaughlin; J Olsen; J H Olsen
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

Review 2.  Update on epidemiology and therapeutics for non-Hodgkin's lymphoma.

Authors:  Julie M Vose; Brian C-H Chiu; Bruce D Cheson; Janet Dancey; John Wright
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2002

Review 3.  Lymphocytes transport serotonin and dopamine: agony or ecstasy?

Authors:  John Gordon; Nicholas M Barnes
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

4.  Antidepressant medication use and non-Hodgkin's lymphoma risk: no association.

Authors:  Saira Bahl; Michelle Cotterchio; Nancy Kreiger; Neil Klar
Journal:  Am J Epidemiol       Date:  2004-09-15       Impact factor: 4.897

Review 5.  Stress, depression, and psychoneuroimmunology.

Authors:  J Kaye; J Morton; M Bowcutt; D Maupin
Journal:  J Neurosci Nurs       Date:  2000-04       Impact factor: 1.230

6.  Chronically depressed mood and cancer risk in older persons.

Authors:  B W Penninx; J M Guralnik; M Pahor; L Ferrucci; J R Cerhan; R B Wallace; R J Havlik
Journal:  J Natl Cancer Inst       Date:  1998-12-16       Impact factor: 13.506

7.  The person-number systems of Sweden, Norway, Denmark, and Israel.

Authors:  A S Lunde; S Lundeborg; G S Lettenstrom; L Thygesen; J Huebner
Journal:  Vital Health Stat 2       Date:  1980

Review 8.  A systematic review of the mortality of depression.

Authors:  L R Wulsin; G E Vaillant; V E Wells
Journal:  Psychosom Med       Date:  1999 Jan-Feb       Impact factor: 4.312

9.  Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus.

Authors:  Lena Björnådal; Björn Löfström; Li Yin; Ingrid E Lundberg; Anders Ekbom
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

Review 10.  Depression, adrenal steroids, and the immune system.

Authors:  A H Miller; R L Spencer; B S McEwen; M Stein
Journal:  Ann Med       Date:  1993-10       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.